Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University
Summary
This is a multicenter, double-blind, randomized controlled clinical trial to get high - level evidence on minocycline's efficacy and safety(100mg/d, 200mg/d) for Retinitis pigmentosa and to find the optimal treatment dose.
Official title: A Multicenter, Double-Blind, Randomized Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
126
Start Date
2025-07-15
Completion Date
2028-06-30
Last Updated
2025-07-24
Healthy Volunteers
No
Interventions
Minocycline 100mg
Capsules Minocycline 100mg po per day and placebo 100mg po per day for 12 months
Minocycline 200mg
Capsules Minocycline 100mg po twice a day for 12 months
Placebo
Capsules placebo 100mg po twice a day for 12 months
Locations (1)
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China